Screening and validation of potential molecular markers for colorectal cancer: based on bioinformatics analysis and machine learning
Open Access
- 22 February 2026
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 26 (1)
Abstract
Colorectal Cancer (CRC) exhibits persistently high incidence and mortality rates worldwide, imposing a substantial socioeconomic burden. Early screening, early diagnosis, and early treatment can significantly improve patients’ survival rates while reducing mortality. However, there remains a lack of effective biomarkers to aid in early screening and diagnosis. As a branch of artificial intelligence, machine learning can automatically analyze large volumes of data, greatly saving human time and resources. The advancement of high-throughput sequencing technology has provided researchers with abundant gene expression data, offering rich data resources for the training and validation of machine learning models. With the development of artificial intelligence, integrating knowledge from bioinformatics, machine learning, molecular biology, and clinical medicine for analysis enables a more comprehensive understanding and exploration of the molecular biological mechanisms underlying CRC. In summary, this project aims to utilize machine learning techniques to screen five CRC signature genes (ABCG2, SCGN, USP2, CLDN1, and EPHX4) from GEO datasets, validate these signature genes using TCGA database, and perform RT-qPCR to detect the relative mRNA expression levels of these genes in CRC. Ultimately, this study seeks to provide novel biomolecular markers for the early diagnosis of CRC.Keywords
This publication has 31 references indexed in Scilit:
- The prognostic significance of epoxide hydrolases in colorectal cancerBiochemistry and Biophysics Reports, 2025
- The role of ABCG2 in health and disease: Linking cancer therapy resistance and other disordersLife Sciences, 2024
- Comprehensive analysis of the immune implication of EPHX4 gene in laryngeal squamous cell carcinomaBrazilian Journal of Otorhinolaryngology, 2024
- SCGN and STAT3 expressions are associated with the prognosis of ccRCCPathology - Research and Practice, 2023
- Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancerCancer Letters, 2023
- Machine Learning for Lung Cancer Diagnosis, Treatment, and PrognosisGenomics, Proteomics & Bioinformatics, 2022
- Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulatorsEuropean Journal of Medicinal Chemistry, 2022
- Data mining and machine learning in cancer survival research: An overview and future recommendationsJournal of Biomedical Informatics, 2022
- Machine Learning in Epigenomics: Insights into Cancer Biology and MedicineBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Overexpression of secretagogin promotes cell apoptosis and inhibits migration and invasion of human SW480 human colorectal cancer cellsBiomedicine & Pharmacotherapy, 2018